Clearside Biomedical, Inc. (CLSD): Price and Financial Metrics
Clearside Biomedical, Inc. (CLSD)
Today's Latest Price: $1.95 USD
Updated Nov 27 1:00pm
Add CLSD to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
CLSD Stock Summary
- For CLSD, its debt to operating expenses ratio is greater than that reported by just 10.66% of US equities we're observing.
- With a year-over-year growth in debt of -82.34%, Clearside Biomedical Inc's debt growth rate surpasses only 2.8% of about US stocks.
- Revenue growth over the past 12 months for Clearside Biomedical Inc comes in at 3,664.37%, a number that bests 99.69% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Clearside Biomedical Inc are TRVN, KIN, MOTS, GBT, and OCX.
- CLSD's SEC filings can be seen here. And to visit Clearside Biomedical Inc's official web site, go to www.clearsidebio.com.
CLSD Stock Price Chart Interactive Chart >
CLSD Price/Volume Stats
| Current price | $1.95 | 52-week high | $4.13 |
| Prev. close | $1.96 | 52-week low | $1.10 |
| Day low | $1.92 | Volume | 363,400 |
| Day high | $2.08 | Avg. volume | 516,347 |
| 50-day MA | $1.53 | Dividend yield | N/A |
| 200-day MA | $1.83 | Market Cap | 94.29M |
Clearside Biomedical, Inc. (CLSD) Company Bio
Clearside Biomedical, a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. The company was founded in 2011 and is based in Alpharetta, Georgia
Loading social stream, please wait...